Changes in Visual Long-Term Potentiation Show Preserved Cyclicity in Human Females Taking Combined Oral Contraceptives.

Combined oral contraceptive pill Dynamic causal modelling Electroencephalography Gonadal hormones Long-term potentiation

Journal

Neuroendocrinology
ISSN: 1423-0194
Titre abrégé: Neuroendocrinology
Pays: Switzerland
ID NLM: 0035665

Informations de publication

Date de publication:
2023
Historique:
received: 15 11 2022
accepted: 18 04 2023
medline: 26 7 2023
pubmed: 25 4 2023
entrez: 24 04 2023
Statut: ppublish

Résumé

The combined oral contraceptive (COC) pill is often employed to address physical and neurological symptoms in menstrual cycle-related disorders by suppressing shifts in endogenous gonadal hormone fluctuations. Symptom persistence, especially in the lead up to the hormone-free interval (HFI), suggests an underlying neurobiological mechanism of preserved cycling. Our study utilised a non-invasive method of visually inducing long-term potentiation (LTP) to index changes in neural plasticity in the absence of hormonal fluctuations. Visually induced LTP was recorded using electroencephalography in 24 healthy female COC users across three sessions: days 3 and 21 during active hormone pills, and day 24 during the HFI. The Daily Record of the Severity of Problems (DRSP) questionnaire tracked premenstrual symptoms. Dynamic causal modelling (DCM) was used to elucidate the neural connectivity and receptor activity changes associated with LTP across different days of COC. Visually induced LTP was greater on day 21 than day 3 (p = 0.011) and was localised to the P2 visually evoked potential. There was no effect of the HFI (day 24) on LTP. DCM of differences between days 3 and 21 showed changes to inhibitory interneuronal gating of LTP in cortical layer VI. The DRSP only showed a significant increase in symptoms in the HFI, meaning the LTP result appeared more sensitive to cyclicity. This study provides objective evidence of preserved cyclicity in COC users through enhanced LTP on day 21 compared to day 3 of a 28-day COC regimen, indicating that relatively higher excitation in the brain despite peripheral gonadal suppression may underlie and exacerbate menstrual cycle-related disorders.

Identifiants

pubmed: 37094560
pii: 000530805
doi: 10.1159/000530805
pmc: PMC10389802
doi:

Substances chimiques

Contraceptives, Oral, Combined 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

859-874

Informations de copyright

© 2023 The Author(s). Published by S. Karger AG, Basel.

Références

Neuroimage. 2008 Oct 1;42(4):1490-8
pubmed: 18639641
Epilepsy Res. 2009 Jul;85(1):1-30
pubmed: 19406620
J Neurosci. 2014 May 28;34(22):7575-9
pubmed: 24872561
Clin Chim Acta. 2019 Aug;495:198-204
pubmed: 30981845
Obstet Gynecol. 2000 Feb;95(2):261-6
pubmed: 10674591
Sci Rep. 2020 Dec 17;10(1):22237
pubmed: 33335211
Am J Obstet Gynecol. 2009 Aug;201(2):139.e1-8
pubmed: 19398092
Front Comput Neurosci. 2013 May 28;7:57
pubmed: 23755005
Psychoneuroendocrinology. 2021 Nov;133:105426
pubmed: 34597899
Cleve Clin J Med. 2004 Feb;71 Suppl 2:S4-10
pubmed: 15379294
Hum Reprod. 2011 Mar;26(3):678-84
pubmed: 21227943
Front Neurosci. 2015 Feb 20;9:37
pubmed: 25750611
J Neurosci. 2015 Aug 19;35(33):11694-706
pubmed: 26290246
PLoS Comput Biol. 2021 Jan 21;17(1):e1008414
pubmed: 33476341
Hum Brain Mapp. 2018 Aug;39(8):3187-3202
pubmed: 29665216
Expert Opin Pharmacother. 2001 Sep;2(9):1367-82
pubmed: 11585017
J Neuroendocrinol. 2022 Feb;34(2):e13013
pubmed: 34337790
Nat Neurosci. 2008 Mar;11(3):334-43
pubmed: 18297067
Front Neuroendocrinol. 2023 Jan;68:101040
pubmed: 36243109
Psychoneuroendocrinology. 2017 Jun;80:46-55
pubmed: 28319848
Epilepsia. 2001 Mar;42(3):328-36
pubmed: 11442149
Neuroimage. 2019 Oct 15;200:12-25
pubmed: 31226492
Obstet Gynecol Int. 2013;2013:487143
pubmed: 23577032
Contraception. 2005 Jan;71(1):1-7
pubmed: 15639064
J Neurosci. 1990 Apr;10(4):1286-91
pubmed: 2329377
Arch Womens Ment Health. 2006 Jan;9(1):1-14
pubmed: 16206030
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jan;5(1):45-55
pubmed: 31495712
Annu Rev Neurosci. 1987;10:131-61
pubmed: 3032063
Contraception. 1996 Nov;54(5):299-304
pubmed: 8934064
Neuroimage. 2020 Nov 1;221:117189
pubmed: 32711064
J Med Invest. 1997 Aug;44(1-2):41-6
pubmed: 9395716
Brain Res. 2015 Sep 24;1621:170-86
pubmed: 25542386
Biol Psychiatry. 2012 Mar 15;71(6):496-502
pubmed: 21974785
J Neurosci. 1994 Dec;14(12):7680-7
pubmed: 7996203
Annu Rev Neurosci. 2004;27:419-51
pubmed: 15217339
Eur J Neurosci. 2018 Aug;48(4):2084-2097
pubmed: 30025183
Pharmacol Biochem Behav. 2006 Aug;84(4):628-34
pubmed: 16854457
Neurosci Biobehav Rev. 2020 Aug;115:220-237
pubmed: 32562886
Brain Res Bull. 2008 May 15;76(1-2):97-101
pubmed: 18395617
Brain Res. 1995 Dec 12;703(1-2):26-30
pubmed: 8719612
Clin Neurophysiol. 2004 May;115(5):1063-8
pubmed: 15066531
Neurobiol Learn Mem. 2018 Nov;155:422-434
pubmed: 30172951
Eur J Neurosci. 2005 Apr;21(7):2045-50
pubmed: 15869500
Obstet Gynecol. 2005 Sep;106(3):492-501
pubmed: 16135578
J Clin Endocrinol Metab. 1996 Mar;81(3):1076-82
pubmed: 8772579
J Neurosci. 2005 Aug 24;25(34):7780-91
pubmed: 16120779
Ann N Y Acad Sci. 2003 Dec;1007:42-53
pubmed: 14993039
Contraception. 2005 Dec;72(6):414-21
pubmed: 16307962
J Neurosci. 1998 Apr 1;18(7):2550-9
pubmed: 9502814
J Neurosci. 2020 Feb 19;40(8):1640-1649
pubmed: 31915255
Neuroimage. 2018 Aug 1;176:290-300
pubmed: 29715566
J Neurosci. 1994 Mar;14(3 Pt 2):1634-45
pubmed: 8126560
Contraception. 2008 Mar;77(3):162-70
pubmed: 18279685
J Psychosom Res. 1993;37(2):195-202
pubmed: 8463994
Neurology. 1999 Dec 10;53(9):2069-72
pubmed: 10599783
Wiley Interdiscip Rev Cogn Sci. 2010 Sep;1(5):766-773
pubmed: 26271660
Fertil Steril. 2006 May;85(5):1371-8
pubmed: 16580672
Open Access J Contracept. 2019 Sep 20;10:27-39
pubmed: 31572029
Neurosci Lett. 1999 Dec 17;277(1):45-8
pubmed: 10643894
Eur Neuropsychopharmacol. 2020 Sep;38:73-85
pubmed: 32763021
Schizophr Bull. 2020 Feb 26;46(2):345-353
pubmed: 31219602
Acta Obstet Gynecol Scand. 2000 May;79(5):405-13
pubmed: 10830769
Biol Psychiatry. 2012 Mar 15;71(6):512-20
pubmed: 22364738
Am J Obstet Gynecol. 2003 Dec;189(6):1523-30
pubmed: 14710055
Front Neuroendocrinol. 2020 Oct;59:100856
pubmed: 32730861
J Reprod Med. 2002 Jan;47(1):14-22
pubmed: 11838304
Neuroimage. 2017 Nov 1;161:19-31
pubmed: 28807873
J Neurosci. 2001 Dec 15;21(24):9801-13
pubmed: 11739588
Cereb Cortex. 2021 Feb 5;31(3):1837-1847
pubmed: 31216360
Am J Obstet Gynecol. 1999 Nov;181(5 Pt 2):53-8
pubmed: 10561676
Biol Psychiatry. 2007 Sep 1;62(5):373-80
pubmed: 17240361
Annu Rev Pharmacol Toxicol. 2007;47:657-80
pubmed: 16918306

Auteurs

Elizabeth Stone (E)

School of Psychology, University of Auckland, Auckland, New Zealand, esto495@aucklanduni.ac.nz.

Malak Alshakhouri (M)

School of Pharmacy, University of Auckland, Auckland, New Zealand.

Alexander Shaw (A)

Department of Psychology, Exeter University, Exeter, UK.

Suresh Muthukumaraswamy (S)

School of Pharmacy, University of Auckland, Auckland, New Zealand.

Rachael L Sumner (RL)

School of Pharmacy, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH